Centrica plc (LON:CNA – Get Free Report) insider Amber Rudd purchased 1,635 shares of Centrica stock in a transaction dated Friday, October 25th. The shares were acquired at an average cost of GBX 122 ($1.58) per share, for a total transaction of £1,994.70 ($2,589.85).
Amber Rudd also recently made the following trade(s):
- On Wednesday, September 25th, Amber Rudd bought 1,668 shares of Centrica stock. The shares were acquired at an average cost of GBX 119 ($1.55) per share, for a total transaction of £1,984.92 ($2,577.15).
- On Tuesday, August 27th, Amber Rudd purchased 1,561 shares of Centrica stock. The stock was acquired at an average cost of GBX 127 ($1.65) per share, with a total value of £1,982.47 ($2,573.97).
Centrica Price Performance
Centrica stock opened at GBX 123.25 ($1.60) on Friday. The company has a current ratio of 1.77, a quick ratio of 0.40 and a debt-to-equity ratio of 61.65. The company has a fifty day simple moving average of GBX 122.46 and a 200-day simple moving average of GBX 130.32. The stock has a market cap of £6.40 billion, a P/E ratio of 560.23, a price-to-earnings-growth ratio of 0.45 and a beta of 1.08. Centrica plc has a 12-month low of GBX 113.90 ($1.48) and a 12-month high of GBX 165.15 ($2.14).
Analysts Set New Price Targets
View Our Latest Research Report on CNA
About Centrica
Centrica plc operates as an integrated energy company in the United Kingdom, Ireland, Scandinavia, North America, and internationally. The company operates through British Gas Services & Solutions, British Gas Energy, Centrica Business Solutions, Bord Gáis Energy, Centrica Energy, and Upstream segments.
Read More
- Five stocks we like better than Centrica
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Texas Roadhouse Stock Steering for New Highs This Year
- Using the MarketBeat Dividend Tax Calculator
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Centrica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centrica and related companies with MarketBeat.com's FREE daily email newsletter.